Comments on Proposed Rule Regarding Approach to PFAS Reporting Requirements and Supplier Notification for Chemicals of Special Concern Share page: Docket Number: EPA–HQ–TRI–2022–0270 Download Document Issues: OTC Medicines Dietary Supplements Consumer Medical Devices Other Issues Packaging Sustainability PFAS Related Posts Regulation of OTC Medicines Press Releases and Statements CHPA Congratulates Dr. Doug Bierer as First Recipient of the William Cooley Regulatory & Scientific Affairs Career Achievement Award Sep 18, 2024 Press Releases and Statements Health In Hand Foundation Announces 2024 U.S. Self-Care Marketing Awards Finalists Sep 9, 2024